LightAir has signed a distribution agreement for the US market with market-leading Almo Corporation. The collaboration begins immediately with a first order for Swedish-developed air purifiers, valued at approximately SEK 2 million.
LightAir IonFlow virus inhibitor is scientifically and independently proven on viruses in the air and on surfaces, and together with the development of vaccines, can actively contribute to halting the spread of COVID-19.